Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA as a drug target

N D Pearson1, C D Prescott

  • 1Department of Medicinal Chemistry, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, Essex, CM19 5AW, UK. neil_pearson-1@sbphrd.com

Chemistry & Biology
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The carbenoid approach to peptide synthesis.

Chemistry (Weinheim an der Bergstrasse, Germany)·2000
Same author

The structure of ribonuclease P protein from Staphylococcus aureus reveals a unique binding site for single-stranded RNA.

Journal of molecular biology·2000
Same author

Structure-based and combinatorial search for new RNA-binding drugs.

Current opinion in biotechnology·1999
Same author

The N terminus of eukaryotic translation elongation factor 3 interacts with 18 S rRNA and 80 S ribosomes.

The Journal of biological chemistry·1998
Same author

The selection in vivo and characterization of an RNA recognition motif for spectinomycin.

Bioorganic & medicinal chemistry·1997
Same author

Throwing a spanner in the works: antibiotics and the translation apparatus.

Journal of molecular medicine (Berlin, Germany)·1996

RNA is emerging as a viable drug target, shifting focus from traditional protein targets. Advances in RNA synthesis and structure determination enable its systematic exploitation for new therapeutics.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • The pharmaceutical industry has historically prioritized protein targets for drug development.
  • Nucleic acids, particularly RNA, have been underexplored as therapeutic targets.
  • Recent scientific breakthroughs are changing this paradigm.

Purpose of the Study:

  • To highlight the potential of RNA as a drug target.
  • To discuss the enabling advances in RNA research.
  • To advocate for the systematic exploitation of RNA targets.

Main Methods:

  • Review of recent advances in RNA synthesis.
  • Analysis of novel RNA structure determination techniques.
  • Identification of emerging RNA therapeutic targets.

Related Experiment Videos

Main Results:

  • RNA synthesis technologies have matured significantly.
  • Advanced methods for determining RNA structures are now available.
  • Systematic identification of RNA molecules as drug targets is becoming feasible.

Conclusions:

  • RNA represents a promising and largely untapped class of drug targets.
  • Technological progress supports the development of RNA-targeted therapeutics.
  • The pharmaceutical industry should increasingly consider RNA targets for drug discovery.